Latest common stock for ALNA: $110K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Allena Pharmaceuticals (ALNA) currently reports a common stock of $110K as of June 2022. That compares with $59K in the prior-year period — up 83.1% year over year. Use the charts on this page to explore Allena Pharmaceuticals's common stock history and peer comparisons.
Allena Pharmaceuticals's common stock increased from $59K to $110K — a 83.1% year-over-year increase (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Allena Pharmaceuticals reported $110K in common stock as of June 2022. That compares with $59K in the prior-year period — up 83.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $110K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Allena Pharmaceuticals, and consider following ALNA for alerts when major investors trade the stock.
Allena Pharmaceuticals is classified in the Healthcare sector. On common stock, it currently shows $110K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALNA with unrelated industries.